Evaluating equality in prescribing Novel Oral Anticoagulants (NOACs) in England: The protocol of a Bayesian small area analysis.
<h4>Background</h4>Atrial fibrillation (AF) is the most common cardiac arrhythmia, affecting about 1.6% of the population in England. Novel oral anticoagulants (NOACs) are approved AF treatments that reduce stroke risk. In this study, we estimate the equality in individual NOAC prescript...
Main Authors: | Ehsan Rezaei-Darzi, Parinaz Mehdipour, Mariachiara Di Cesare, Farshad Farzadfar, Shadi Rahimzadeh, Lisa Nissen, Alireza Ahmadvand |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0246253 |
Similar Items
-
Non-vitamin K dependent oral anticoagulants (NOACs) controls
by: Persson, Anna
Published: (2018) -
Nonvitamin K antagonist oral anticoagulants (NOACs): the tide continues to come in
by: Blann A
Published: (2015-08-01) -
Non-vitamin K oral anticoagulants (NOACs) in patients with stroke and atrial fibrillation
by: Jovanović Dejana R.
Published: (2020-01-01) -
Geographical and socioeconomic inequalities in female breast cancer incidence and mortality in Iran: A Bayesian spatial analysis of registry data.
by: Shadi Rahimzadeh, et al.
Published: (2021-01-01) -
Safety of once- or twice-daily dosing of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with nonvalvular atrial fibrillation: A NOAC-TR study
by: Sadık Volkan Emren, et al.
Published: (2018-05-01)